The Medicare Cognitive Assessment and Care Plan Services benefit gives every Georgia Medicare beneficiary suspected of having or diagnosed with cognitive impairment — including mild cognitive impairment (MCI), Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, mixed dementias, and other cognitive disorders — the right to receive a comprehensive cognitive evaluation with structured care plan development. The service is billed under CPT 99483 (Assessment of and care planning for a patient with cognitive impairment, typically 50 minutes face-to-face), which became effective January 1, 2018 under the CY 2018 Medicare Physician Fee Schedule final rule. CPT 99483 replaced HCPCS G0505 (Cognition and functional assessment by the physician or other qualified health care professional in office or other outpatient setting), which had been established effective January 1, 2017 under the CY 2017 Medicare Physician Fee Schedule final rule (CMS-1654-F, published November 15, 2016).
The Cognitive Assessment and Care Plan Services benefit recognizes that comprehensive cognitive evaluation requires substantially more clinical work than standard Evaluation and Management (E/M) codes capture. Standard E/M codes for new patient visits or established patient visits, even at the highest complexity levels, do not adequately reimburse the time and structured elements required for thorough cognitive assessment. The 50-minute (typical face-to-face) duration of CPT 99483 reflects the substantial workup required: detailed history-taking from both the patient and caregiver, formal cognitive testing, functional assessment, safety assessment, caregiver assessment, neuropsychiatric symptom assessment, medication reconciliation, advance care planning discussion, comprehensive care plan development, and community resource referrals.
For Georgia Medicare beneficiaries, the cognitive assessment benefit operates within a state landscape that includes approximately 189,000 Georgia residents age 65 and older living with Alzheimer's disease (per Alzheimer's Association estimates), a substantial population of beneficiaries with MCI (estimated at 10-15% of community-dwelling older adults), and a state infrastructure that includes the Georgia State Plan for Alzheimer's Disease and Related Dementias coordinated through the Georgia Department of Human Services Division of Aging Services. Georgia's academic medical center memory care infrastructure is anchored by the Emory Goizueta Alzheimer's Disease Research Center (one of approximately 35 NIA-designated Alzheimer's Disease Research Centers nationally), the Emory Brain Health Center, the Augusta University Brain Health Initiative, and additional memory care programs at Wellstar, Piedmont, Atrium Health Navicent, Northeast Georgia, and the Atlanta VA Health Care System. The Alzheimer's Association Georgia Chapter provides patient and family support services, education, and connection to clinical resources across the state.
The cognitive assessment benefit also operates within a federal framework that has substantially expanded over the past decade. The National Alzheimer's Project Act (NAPA, Public Law 111-375) signed into law January 4, 2011, established the federal coordination framework for Alzheimer's disease research, services, and public health. The BOLD Infrastructure for Alzheimer's Act (Public Law 115-406, signed December 31, 2018) established CDC public health infrastructure for cognitive health surveillance, intervention, and dementia caregiving support, with reauthorization in 2024 continuing this framework. The 21st Century Cures Act (December 13, 2016) Section 11003 reinforced the NAPA framework. CMS's establishment of HCPCS G0505 in 2017 and CPT 99483 in 2018 represented the most substantial Medicare payment innovation supporting comprehensive cognitive assessment in primary care and specialty settings.
This guide explains how the Medicare Cognitive Assessment and Care Plan Services benefit works statutorily and clinically, what the 10 required structural elements of CPT 99483 each require, how CPT 99483 relates to the HCPCS G0505 predecessor code, who is eligible for cognitive assessment, what the caregiver involvement requirement means in practice, how cognitive assessment coordinates with the Annual Wellness Visit cognitive impairment detection element, how cognitive assessment coordinates with Chronic Care Management and Behavioral Health Integration for ongoing dementia care, what telehealth cognitive assessment looks like for rural Georgia beneficiaries, what Major Georgia memory care and geriatric programs deliver cognitive assessment, and why cognitive assessment coverage matters for every Georgia Medicare beneficiary suspected of having or diagnosed with cognitive impairment.
Key Takeaways for Georgia Medicare Beneficiaries
CPT 99483 is the Medicare Cognitive Assessment and Care Plan Services code, effective January 1, 2018 under the CY 2018 Medicare Physician Fee Schedule final rule. CPT 99483 covers a typical 50-minute face-to-face comprehensive cognitive evaluation with structured care plan development.
HCPCS G0505 predecessor — CPT 99483 replaced HCPCS G0505, which was effective January 1, 2017 under the CY 2017 Medicare Physician Fee Schedule final rule (CMS-1654-F, published November 15, 2016). The CY 2017 G0505 framework established the original Medicare cognitive assessment payment, with the CPT 99483 successor preserving the structural framework while transitioning to the standard CPT coding.
10 required structural elements — CPT 99483 requires 10 specific structural elements distinguishing it from standard E/M codes: (1) cognition-focused evaluation, (2) medical decision making of moderate or high complexity, (3) functional assessment using standardized instruments, (4) safety assessment including driving and home safety, (5) caregiver assessment, (6) advance care planning discussion, (7) medication reconciliation, (8) comprehensive care plan, (9) neuropsychiatric and behavioral symptom assessment, and (10) referrals to community resources.
MCI and dementia eligibility — Beneficiaries with mild cognitive impairment, Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, mixed dementias, or other cognitive disorders are eligible. The service supports both initial diagnostic workup and ongoing care plan development.
Caregiver involvement — The caregiver assessment element typically requires participation of a family member, friend, or other person who provides care or could potentially provide care for the beneficiary. The caregiver provides collateral history and is engaged in care planning.
Annual frequency limit — CPT 99483 is typically billed once per year per beneficiary. Re-evaluation may occur as clinically indicated for substantial changes in cognitive status.
Standard Part B cost-sharing — CPT 99483 is subject to the standard Part B deductible plus 20% coinsurance. It is NOT subject to the ACA Section 4104 preventive services cost-sharing waiver.
AWV coordination — The Annual Wellness Visit includes a cognitive impairment detection element. When AWV identifies cognitive concerns, follow-up CPT 99483 cognitive assessment is the appropriate next step. CPT 99483 and AWV can be billed in the same calendar month when both are clinically appropriate.
CCM and BHI coordination — Following CPT 99483 diagnosis and care planning, ongoing dementia care commonly involves Chronic Care Management (CPT 99490) for medical coordination and Behavioral Health Integration (CPT 99484) for neuropsychiatric symptom management.
For Georgia beneficiaries, comprehensive cognitive assessment is delivered by Major Georgia memory care programs (Emory Goizueta ADRC, Emory Brain Health Center, Augusta University Brain Health Initiative, Wellstar Memory Health Network, Piedmont memory care, Atrium Health Navicent, Memorial Health, Phoebe Putney, Northeast Georgia, Atlanta VA Geriatrics), with telehealth cognitive assessment expanding access for rural Georgia beneficiaries.
The Federal Framework Underlying the Cognitive Assessment Benefit
HCPCS G0505 — Predecessor Code Effective January 1, 2017
The Medicare Cognitive Assessment benefit was first established through HCPCS G0505 effective January 1, 2017 under the CY 2017 Medicare Physician Fee Schedule final rule (CMS-1654-F, published in the Federal Register on November 15, 2016). The CY 2017 final rule recognized that the existing E/M code framework did not adequately reimburse the comprehensive cognitive assessment work required for MCI and dementia evaluation, particularly the time-intensive caregiver involvement, functional assessment, safety assessment, and care plan development elements.
The CY 2017 G0505 framework was structured as follows:
HCPCS G0505 — Cognition and functional assessment by the physician or other qualified health care professional in office or other outpatient setting; with the following required elements: (a) cognition-focused evaluation including a pertinent history and examination; (b) medical decision making of moderate or high complexity; (c) functional assessment (e.g., basic and instrumental activities of daily living), including decision-making capacity; (d) use of standardized instruments to stage dementia; (e) medication reconciliation and review for high-risk medications, if applicable; (f) evaluation for neuropsychiatric and behavioral symptoms, including depression, including use of standardized instrument(s); (g) evaluation of safety (e.g., home), including motor vehicle operation, if applicable; (h) identification of caregiver(s), caregiver knowledge, caregiver needs, social supports, and the willingness of caregiver to take on caregiving tasks; (i) development, updating or revision, or review of an Advance Care Plan; (j) creation of a written care plan, including initial plans to address any neuropsychiatric symptoms, neuro-cognitive symptoms, functional limitations, and referral to community resources as needed (e.g., rehabilitation services, adult day programs, support groups) shared with the patient and/or caregiver with initial education and support. Typical time: 50 minutes face-to-face.
The CY 2017 G0505 framework operated for one calendar year before being replaced by CPT 99483 in 2018.
CPT 99483 — Replaced G0505 Effective January 1, 2018
Effective January 1, 2018 under the CY 2018 Medicare Physician Fee Schedule final rule, CMS replaced HCPCS G0505 with CPT 99483 (Assessment of and care planning for a patient with cognitive impairment, requiring an independent historian, in office or other outpatient, home or domiciliary or rest home with required elements; typically 50 minutes are spent face-to-face with the patient and/or family or caregiver).
The CPT 99483 framework preserves all 10 required structural elements of the G0505 predecessor with substantively identical content, expressed in CPT coding format:
- Cognition-focused evaluation including a pertinent history and examination
- Medical decision making of moderate or high complexity
- Functional assessment (e.g., basic and instrumental activities of daily living), including decision-making capacity
- Use of standardized instruments to stage dementia (e.g., functional assessment staging test (FAST), Clinical Dementia Rating (CDR))
- Medication reconciliation and review for high-risk medications, if applicable
- Evaluation for neuropsychiatric and behavioral symptoms, including depression, including use of standardized instrument(s)
- Evaluation of safety (e.g., home), including motor vehicle operation, if applicable
- Identification of caregiver(s), caregiver knowledge, caregiver needs, social supports, and the willingness of caregiver to take on caregiving tasks
- Development, updating, revision, or review of an Advance Care Plan
- Creation of a written care plan, including initial plans to address any neuropsychiatric symptoms, neuro-cognitive symptoms, functional limitations, and referral to community resources as needed, shared with the patient and/or caregiver with initial education and support
The CPT 99483 framework is structured around the typical 50-minute face-to-face duration but is not strictly time-based — the code is structurally defined by the 10 required elements and the moderate or high complexity medical decision making. When all 10 elements are satisfied and MDM is moderate or high, CPT 99483 is appropriately billed.
Section 1861(s)(2)(B) — Statutory Authority
The underlying statutory authority for cognitive assessment payment is Section 1861(s)(2)(B) of the Social Security Act, authorizing Medicare payment for physician services. CMS establishes cognitive assessment-specific codes within the Section 1861(s)(2)(B) framework through the Medicare Physician Fee Schedule rulemaking process.
42 CFR 410.26 — Incident-To Framework
42 CFR 410.26 establishes the Medicare incident-to framework. While CPT 99483 is principally a physician/QHP-furnished service (the 50-minute typical face-to-face time captures physician/QHP time), incident-to provisions support clinical staff involvement in elements such as administering standardized instruments and gathering caregiver information.
The Annual Wellness Visit Cognitive Impairment Detection Element
Section 1861(hhh) of the Social Security Act (as added by ACA Section 4103, effective January 1, 2011) establishes the Annual Wellness Visit (AWV). The AWV includes "detection of any cognitive impairment" as a required element. The cognitive impairment detection element does NOT prescribe a specific instrument but requires the practitioner to use clinical judgment and any patient or caregiver concerns to identify potential cognitive impairment. When AWV cognitive impairment detection identifies concerns warranting comprehensive evaluation, the appropriate next step is referral for CPT 99483 cognitive assessment (or a comprehensive cognitive workup billed as appropriate E/M codes combined with additional testing).
The BOLD Infrastructure for Alzheimer's Act
The BOLD (Building Our Largest Dementia) Infrastructure for Alzheimer's Act (Public Law 115-406) was signed into law December 31, 2018, establishing CDC public health infrastructure for cognitive health surveillance, intervention, and dementia caregiving support. The BOLD Act created three areas of CDC investment: (1) Centers of Excellence focused on cognitive health, early detection and diagnosis, and dementia caregiving; (2) public health programs in state and local health departments; and (3) cognitive health data infrastructure through enhanced surveillance. The BOLD Act was reauthorized in 2024, continuing the public health infrastructure framework. The BOLD Act complements the CMS cognitive assessment payment infrastructure (CPT 99483) by building public health capacity for cognitive health intervention and dementia caregiving support.
National Alzheimer's Project Act (NAPA)
The National Alzheimer's Project Act (Public Law 111-375), signed into law January 4, 2011, established the federal coordination framework for Alzheimer's disease research, services, and public health. NAPA required development and ongoing updating of a National Plan to Address Alzheimer's Disease, established the Advisory Council on Alzheimer's Research, Care, and Services, and coordinated federal investment across HHS agencies including NIH (research), CMS (payment), CDC (public health), and HRSA (workforce). The 21st Century Cures Act (December 13, 2016) Section 11003 reinforced the NAPA framework with additional research investment authorizations.
The 10 Required Structural Elements of CPT 99483
CPT 99483 requires all 10 structural elements to be satisfied for the code to be appropriately billed. The elements collectively define the comprehensive cognitive assessment that distinguishes CPT 99483 from standard E/M codes:
Element 1: Cognition-Focused Evaluation
The cognition-focused evaluation includes pertinent history and examination focused on the cognitive complaint. Components typically include:
- Detailed cognitive history — Onset and progression of cognitive symptoms, specific cognitive domains affected (memory, executive function, language, visuospatial, social cognition, attention), pattern of decline, fluctuation, associated symptoms (hallucinations, parkinsonism, gait disturbance, behavioral changes)
- Medical history — Vascular risk factors, head injury history, alcohol use, sleep disorders, depression/anxiety history, family history of dementia
- Medication review — Medications that may contribute to cognitive symptoms (anticholinergics, sedatives, opioids)
- Cognitive examination — Formal cognitive testing using validated instruments such as the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Mini-Cog, or other appropriate instruments
The cognition-focused evaluation distinguishes CPT 99483 from a general medical visit by its specific focus on cognitive presentation.
Element 2: Medical Decision Making of Moderate or High Complexity
CPT 99483 requires medical decision making (MDM) of at least moderate complexity. Most MCI and dementia evaluations meet the moderate or high MDM complexity standard given:
- The number and complexity of problems addressed (cognitive symptoms, often comorbid medical conditions, neuropsychiatric symptoms)
- The amount and complexity of data reviewed (laboratory studies, neuroimaging when obtained, neuropsychological testing when obtained, collateral history from caregivers)
- The risk of complications and morbidity from management decisions (medication management decisions, decision-making capacity determinations, advance care planning)
Element 3: Functional Assessment
Functional assessment evaluates the beneficiary's ability to perform activities of daily living (ADLs) and instrumental activities of daily living (IADLs):
- Basic ADLs — Bathing, dressing, toileting, transferring, continence, feeding
- Instrumental ADLs — Managing finances, managing medications, using transportation, shopping, food preparation, housekeeping, using telephone/technology
Standardized instruments commonly used include the Lawton-Brody IADL Scale, Katz ADL Index, Functional Activities Questionnaire (FAQ), or Bristol Activities of Daily Living Scale.
The functional assessment also addresses decision-making capacity — whether the beneficiary has the cognitive capacity to make specific decisions including medical decisions, financial decisions, and other major life decisions.
Element 4: Standardized Instruments to Stage Dementia
CPT 99483 requires use of standardized instruments to stage dementia. Common dementia staging instruments include:
- Clinical Dementia Rating (CDR) — A 5-point scale (0=none, 0.5=questionable, 1=mild, 2=moderate, 3=severe) based on six domains (memory, orientation, judgment and problem solving, community affairs, home and hobbies, personal care)
- Functional Assessment Staging Test (FAST) — A 7-stage scale describing functional changes in Alzheimer's disease progression
- Global Deterioration Scale (GDS) — A 7-stage scale paralleling the FAST
These instruments enable systematic documentation of dementia severity for clinical communication, prognosis discussion, and care planning.
Element 5: Medication Reconciliation and High-Risk Medication Review
Medication reconciliation includes systematic review of all medications (prescription, over-the-counter, supplements) with particular attention to medications that may contribute to cognitive symptoms or pose elevated risk in older adults with cognitive impairment:
- Anticholinergic medications — Diphenhydramine, oxybutynin, tricyclic antidepressants, cyclobenzaprine, and other anticholinergic agents that may impair cognition
- Benzodiazepines and Z-drugs — Lorazepam, alprazolam, zolpidem, and other GABAergic agents that may impair cognition and balance
- Opioids — Particularly long-acting opioids in older adults
- Other CNS-active medications — Antipsychotics, antiepileptics, muscle relaxants
The American Geriatrics Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults provides systematic guidance for high-risk medication review.
Element 6: Neuropsychiatric and Behavioral Symptom Assessment
Neuropsychiatric and behavioral symptoms are common in dementia and substantially impact quality of life, caregiver burden, and care planning. Assessment includes:
- Depression — Using standardized instruments such as the Geriatric Depression Scale (GDS) or PHQ-9
- Anxiety — Using instruments such as the GAD-7 or Geriatric Anxiety Inventory
- Apathy — Apathy Evaluation Scale or Neuropsychiatric Inventory apathy domain
- Agitation and aggression — Cohen-Mansfield Agitation Inventory or Neuropsychiatric Inventory
- Hallucinations and delusions — Particularly relevant for Lewy body dementia, Alzheimer's disease, and other dementias
- Sleep disturbance — Including REM sleep behavior disorder (suggestive of Lewy body dementia) and other sleep changes
- Eating behavior changes — Particularly relevant for frontotemporal dementia
The Neuropsychiatric Inventory (NPI) or its short forms provide systematic neuropsychiatric symptom assessment across all relevant domains.
Element 7: Safety Assessment
Safety assessment evaluates risks associated with cognitive impairment in the beneficiary's daily environment:
- Driving safety — On-road driving evaluation when indicated, driving cessation discussion when appropriate, reporting to state driver licensing authorities per state-specific requirements
- Home safety — Fall hazards, kitchen safety, medication management safety, wandering risk
- Financial safety — Vulnerability to financial exploitation, ability to manage finances
- Firearm safety — Particularly relevant given elevated suicide risk in some dementia populations and risk of accidental injury
- Cooking and appliance safety — Stove use safety, appliance use safety
The safety assessment informs the comprehensive care plan and may trigger specific interventions such as home safety modifications, driving cessation, or supervision arrangements.
Element 8: Caregiver Assessment
The caregiver assessment is one of the most distinctive elements of CPT 99483, recognizing that effective dementia care depends substantially on caregiver capacity, knowledge, and support. The assessment includes:
- Identification of caregivers — Family members, friends, paid caregivers, or others providing care
- Caregiver knowledge — Understanding of the diagnosis, expected course, available treatments, and care needs
- Caregiver needs — Education, respite care, emotional support, financial resources
- Social supports — Other family members, friends, religious community, neighbors
- Willingness to take on caregiving — Particularly important when transitions in care responsibility are anticipated
The caregiver assessment requires actual caregiver participation in the visit (in person or via communication technology), distinguishing CPT 99483 from standard E/M codes that focus exclusively on the patient encounter.
Element 9: Advance Care Planning
The advance care planning element addresses the beneficiary's preferences for future medical care, recognizing that decision-making capacity may decline as cognitive impairment progresses:
- Discussion of prognosis — Expected course of cognitive impairment and how decision-making capacity may evolve
- Healthcare preferences — Treatment preferences for various future scenarios including hospitalization, life-sustaining treatments, comfort-focused care
- Advance directive review — Existing advance directives reviewed and updated as appropriate; new advance directives initiated when not in place
- Surrogate decision maker — Healthcare power of attorney identification and documentation
- End-of-life preferences — Hospice eligibility discussion when appropriate, MOLST/POLST conversation when state-relevant
The advance care planning element complements separately billable Advance Care Planning services (CPT 99497, CPT 99498) which can be billed in addition to CPT 99483 when more extensive ACP discussion occurs.
Element 10: Comprehensive Written Care Plan with Community Referrals
The comprehensive written care plan is the culminating element of CPT 99483, synthesizing all the assessment elements into a structured plan shared with the patient and caregiver:
- Diagnosis and prognosis summary — Clear statement of the diagnosis (MCI, Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, mixed dementia, other) and expected course
- Treatment plan — Pharmacologic interventions (cholinesterase inhibitors, memantine, anti-amyloid therapies when applicable, neuropsychiatric symptom management), non-pharmacologic interventions (cognitive stimulation, exercise, behavioral approaches)
- Functional support plan — Plans to address functional limitations identified in assessment
- Safety plan — Specific safety interventions identified in safety assessment
- Caregiver support plan — Education resources, respite care options, support groups
- Community resource referrals — Adult day programs, support groups, home and community-based services, legal/financial planning resources, Alzheimer's Association resources
- Follow-up plan — Timing and content of follow-up visits, monitoring plan
The care plan must be documented in writing and shared with the patient and/or caregiver, with initial education and support provided.
CPT 99483 Eligibility Criteria
Cognitive Impairment Diagnosis or Suspicion
CPT 99483 is appropriate for beneficiaries with suspected or established cognitive impairment, including:
- Mild cognitive impairment (MCI) — Cognitive decline beyond expected age-related changes but without significant functional impairment
- Alzheimer's disease — At any stage from mild to severe
- Vascular dementia — Including mixed vascular and Alzheimer's contributions
- Lewy body dementia — Including dementia with Lewy bodies and Parkinson's disease dementia
- Frontotemporal dementia — Including behavioral variant and primary progressive aphasia variants
- Mixed dementias — Common pathology combinations particularly in older adults
- Other cognitive disorders — Including normal pressure hydrocephalus, chronic traumatic encephalopathy, alcohol-related cognitive impairment, HIV-associated neurocognitive disorder, prion disease, and others
The service is appropriate for both initial diagnostic workup and for established cognitive impairment patients receiving comprehensive care plan development or revision.
Caregiver Availability Requirement
CPT 99483 requires the caregiver element, meaning caregiver participation in the assessment is structurally required. Patients without caregivers may have difficulty meeting this element. In some cases, the caregiver may participate via telephone or video if not present in person. The caregiver must provide collateral history and engage in care planning.
Frequency Limitations
CPT 99483 is typically billed once per year per beneficiary. Re-evaluation more frequently may be appropriate when there is substantial change in cognitive status warranting comprehensive re-assessment, but routine annual billing is the standard pattern.
The Standard Part B Cost-Sharing Framework
CPT 99483 is subject to standard Medicare Part B cost-sharing:
- Part B deductible — Annual Part B deductible applies before cost-sharing begins. The Part B deductible is $257 for CY 2025
- 20% coinsurance — After deductible, beneficiary pays 20% of Medicare-approved amount
- NOT subject to ACA Section 4104 preventive services waiver — CPT 99483 is not a preventive service and is subject to standard Part B cost-sharing
- QMB coverage — Beneficiaries with Qualified Medicare Beneficiary status under Georgia Medicaid have cost-sharing covered
- Medigap coverage — Beneficiaries with Medigap plans have Part B cost-sharing covered per plan structure
The standard Part B cost-sharing means CPT 99483 is not free for most beneficiaries. The Medicare-approved amount for CPT 99483 is substantial (reflecting the 50-minute typical face-to-face time), so the 20% coinsurance can represent a meaningful out-of-pocket cost. This should be discussed with beneficiaries during pre-visit consent discussions.
Eligible Providers Furnishing CPT 99483
The following provider types can bill CPT 99483:
- Physicians (MDs and DOs) — Including primary care (family medicine, internal medicine, geriatric medicine), neurology, geriatric psychiatry, and other specialties involved in cognitive assessment
- Nurse Practitioners (NPs) — Operating within their scope of practice; geriatric NPs and adult-gerontology NPs commonly furnish CPT 99483
- Physician Assistants (PAs) — Operating within their scope of practice
- Clinical Nurse Specialists (CNSs)
The 50-minute typical face-to-face time captures physician/QHP time. Clinical staff may support administration of standardized instruments and gathering of caregiver information under appropriate physician supervision.
The Coordination Between CPT 99483 and Other Medicare Services
CPT 99483 and Annual Wellness Visit (AWV)
The AWV includes a cognitive impairment detection element under Section 1861(hhh). When AWV identifies cognitive concerns, follow-up CPT 99483 cognitive assessment is the appropriate comprehensive evaluation. CPT 99483 and AWV can be billed in the same calendar month when both are clinically appropriate and substantively distinct services are performed.
The AWV detection-to-99483 evaluation pathway represents the principal way the Medicare framework supports early identification and comprehensive workup of cognitive impairment.
CPT 99483 and Chronic Care Management (CCM)
Following CPT 99483 diagnosis and care plan development, ongoing dementia care commonly involves CCM (CPT 99490) for medical care coordination across the comorbid chronic conditions typically present in older adults with dementia. CCM enrollment supports ongoing care coordination including:
- Medication management across dementia and comorbid conditions
- Coordination across primary care, neurology/geriatric psychiatry, and other specialists
- Caregiver support and education
- Monitoring of cognitive status and functional changes
- Coordination with community resources
CPT 99483 and CCM are typically separated in time — CPT 99483 is the comprehensive annual cognitive assessment, while CCM is the ongoing monthly care coordination. They can coexist within the same calendar year and can be billed in the same calendar month when both services are appropriate.
CPT 99483 and Behavioral Health Integration (BHI)
Neuropsychiatric and behavioral symptoms of dementia (depression, anxiety, apathy, agitation, hallucinations, sleep disturbance) often warrant ongoing behavioral health management. BHI (CPT 99484) or CoCM (CPT 99492/99493/99494) can support ongoing neuropsychiatric symptom management after the initial CPT 99483 assessment identifies symptoms requiring intervention.
CPT 99483 and Principal Care Management (PCM)
For dementia patients with a single complex chronic condition managed by a specialist (e.g., neurology managing the dementia diagnosis specifically), PCM (CPT 99424-99427) may be appropriate. PCM and CPT 99483 can coexist within the same calendar year.
CPT 99483 and Advance Care Planning (CPT 99497/99498)
While CPT 99483 includes an advance care planning element, more extensive ACP discussion can be billed separately under CPT 99497 (first 30 minutes) and CPT 99498 (each additional 30 minutes). When both services are warranted, both can be billed in the same encounter with appropriate documentation distinguishing the work captured by each code.
CPT 99483 and Standard E/M Codes
CPT 99483 is not typically billed in the same encounter as a separate E/M code for the same cognitive complaint — the 99483 captures the comprehensive cognitive assessment work. However, when distinct E/M work is performed (e.g., for a separate medical complaint), modifier-25 may support both codes.
CPT 99483 and Neuropsychological Testing
Neuropsychological testing performed by a neuropsychologist (CPT 96132, 96133, 96136, 96137, 96138, 96139, 96146) is a separate service typically furnished by a neuropsychologist and billed under those codes. Neuropsychological testing complements CPT 99483 when more detailed cognitive profiling is needed beyond the bedside cognitive testing performed during CPT 99483.
The Telehealth Framework for Cognitive Assessment
Telehealth delivery of cognitive assessment has expanded substantially under Medicare telehealth flexibilities. Key considerations include:
- CPT 99483 telehealth eligibility — Cognitive assessment can be delivered via synchronous audio-video telehealth under current flexibilities. The 50-minute typical face-to-face time can be furnished via video.
- Cognitive testing considerations — Some cognitive testing instruments are validated for video administration (e.g., MoCA video version, telephone-administered cognitive testing instruments). Others may require in-person administration. The specific instruments selected should be appropriate for the modality.
- Caregiver participation — Caregivers can participate via video or telephone, supporting the caregiver element of CPT 99483
- Safety assessment — Home safety assessment can be partially supported by video tour of the home environment; comprehensive in-home safety assessment may require separate in-person home health evaluation
- Driving assessment — Driving safety discussion can occur via telehealth; on-road driving evaluation requires in-person assessment
Telehealth cognitive assessment is particularly important for rural Georgia where the nearest comprehensive memory care program may be at a metropolitan academic medical center. Emory Brain Health Center, Augusta University Brain Health Initiative, and other major Georgia memory care programs have expanded telehealth cognitive assessment to support rural Georgia patients.
Major Georgia Memory Care and Cognitive Assessment Programs
Emory Healthcare — Emory Brain Health Center and Emory Goizueta Alzheimer's Disease Research Center
Emory Healthcare anchors Georgia's comprehensive memory care infrastructure with two complementary programs. The Emory Brain Health Center provides clinical evaluation and management of cognitive disorders across the cognitive disease spectrum. The Emory Goizueta Alzheimer's Disease Research Center is one of approximately 35 NIA-designated Alzheimer's Disease Research Centers nationally, providing comprehensive evaluation, clinical research participation opportunities, and specialized expertise in atypical and complex presentations.
Emory's cognitive assessment services include neurologist and geriatric psychiatrist evaluation, neuropsychological testing, neuroimaging (MRI, PET imaging including amyloid PET and tau PET when indicated), cerebrospinal fluid biomarker testing when indicated, genetic counseling for familial dementia cases, and comprehensive care planning. Emory operates telehealth cognitive assessment supporting patients across Georgia.
Augusta University Health — Brain Health Initiative
The Augusta University Brain Health Initiative provides comprehensive cognitive assessment, dementia care, and research participation opportunities at the Augusta University Medical Center. Augusta University's academic medical center model supports comprehensive evaluation including specialty neurology and neuropsychiatry consultation.
Wellstar Health System
Wellstar operates memory care services across its primary care and specialty network. Wellstar Memory Health Network supports cognitive assessment, dementia diagnosis, and ongoing care management.
Piedmont Healthcare
Piedmont Healthcare delivers cognitive assessment services across its neurology and primary care network. Piedmont's geriatric medicine programs support comprehensive cognitive assessment.
Atrium Health Navicent
Atrium Health Navicent (Macon) provides cognitive assessment services for central Georgia. The Atrium Health system memory care programming supports comprehensive evaluation.
Memorial Health (Savannah)
Memorial Health operates cognitive assessment services for coastal Georgia. The HCA Healthcare affiliation supports system-wide memory care approaches.
Phoebe Putney Health System
Phoebe Putney provides cognitive assessment services for southwest Georgia. The rural southwest Georgia setting makes Phoebe's role particularly important for regional memory care access.
Northeast Georgia Health System
Northeast Georgia Health System (Gainesville) delivers cognitive assessment services for northeast Georgia. The Northeast Georgia neurology and geriatric medicine programs support comprehensive evaluation.
Atlanta VA Health Care System
The Atlanta VA Health Care System Geriatric Research, Education and Clinical Center (GRECC) and Geriatrics Service provide cognitive assessment for veterans. The VA's GRECC model emphasizes specialized geriatric expertise and supports veterans across the broader VA system in Georgia. While VA cognitive assessment is billed under VA coverage rather than CPT 99483 in many cases, the VA framework substantially extends cognitive assessment access for veteran Medicare beneficiaries.
Alzheimer's Association Georgia Chapter
The Alzheimer's Association Georgia Chapter provides patient and family support including the 24/7 Helpline (1-800-272-3900), education programs, support groups, care consultation, and connection to clinical resources across the state. The Georgia Chapter coordinates with all major memory care programs and supports beneficiaries throughout their dementia journey from initial diagnosis to end-stage care.
Rural Georgia Cognitive Assessment Access
Rural Georgia faces substantial challenges in cognitive assessment access given:
- Workforce shortage — Neurology, geriatric psychiatry, geriatric medicine, and neuropsychology workforce is concentrated in metropolitan Atlanta, Augusta, Macon, Savannah, Athens, and a handful of other urban areas. Many rural counties lack on-site specialty cognitive assessment capacity.
- Travel burden — Patients in rural Georgia may face 1-2+ hour travel to the nearest comprehensive memory care program
- Family caregiver constraints — Family caregivers may face work and travel constraints limiting their ability to support multi-hour out-of-region appointments
The Medicare telehealth framework — particularly the expanded behavioral health and cognitive assessment telehealth coverage post-PHE — represents a critical access pathway for rural Georgia cognitive assessment. Emory Brain Health Center, Augusta University Brain Health Initiative, and other metropolitan memory care programs have expanded telehealth services supporting rural Georgia patients.
Rural primary care practices and FQHCs/RHCs can also deliver CPT 99483 directly when staff have the training and time to perform the comprehensive 10-element assessment. Primary care-delivered cognitive assessment is appropriate for many cases, with specialty referral reserved for complex or atypical presentations.
The Georgia State Plan for Alzheimer's Disease and Related Dementias coordinated through the Georgia Department of Human Services Division of Aging Services includes objectives for improving rural cognitive assessment access through telehealth expansion, primary care workforce training, and community-based dementia care navigation.
Six Worked Examples: How CPT 99483 Plays Out for Real Georgia Beneficiaries
Example 1: Fulton County 75-Year-Old Newly Identified MCI Following AWV
A 75-year-old man in Fulton County completes his Annual Wellness Visit at his Emory primary care practice. During the AWV cognitive impairment detection element, the primary care physician administers the Mini-Cog screening instrument and identifies a borderline score. The patient's wife reports recent concerns about memory and difficulty managing finances. The primary care physician schedules a follow-up CPT 99483 cognitive assessment at the Emory Brain Health Center. At the comprehensive evaluation, formal cognitive testing (MoCA) reveals MCI. All 10 elements of CPT 99483 are completed including caregiver assessment with the wife, safety assessment (driving safety discussion), advance care planning discussion, and comprehensive care plan with referrals to community resources. Cost-sharing: Part B deductible (already met) + 20% coinsurance.
Example 2: DeKalb County 80-Year-Old Mild Alzheimer's Disease Diagnosis
An 80-year-old woman in DeKalb County is referred to the Emory Goizueta Alzheimer's Disease Research Center for evaluation of two years of progressive memory loss and recent difficulty managing medications. The comprehensive evaluation includes neuropsychological testing, MRI brain imaging, amyloid PET imaging, and CSF biomarker testing in the context of clinical research participation. Clinical assessment confirms mild Alzheimer's disease. CPT 99483 is billed for the comprehensive cognitive assessment and care plan visit. The CDR is 1 (mild dementia), FAST stage 4. The 10 elements are completed including caregiver assessment with the daughter (primary caregiver), safety assessment, advance care planning, medication reconciliation, neuropsychiatric symptom assessment (mild depression identified, BHI referral), and comprehensive care plan with referrals to the Alzheimer's Association Georgia Chapter, adult day program, and home care evaluation.
Example 3: Cobb County 72-Year-Old Mixed Dementia Evaluation at Wellstar
A 72-year-old man in Cobb County has a 3-year history of cognitive decline complicated by multiple vascular risk factors (uncontrolled hypertension, atrial fibrillation, prior small stroke). He is evaluated at Wellstar Memory Health Network. The CPT 99483 evaluation identifies mixed vascular and Alzheimer's contributions. All 10 elements are completed including standardized instrument staging (CDR 1, mild), neuropsychiatric assessment (apathy, mild depression), safety assessment (driving cessation recommended given attention deficits), caregiver assessment with the wife, advance care planning, medication reconciliation (anticholinergic burden reduced), and comprehensive care plan with vascular risk factor optimization, cholinesterase inhibitor initiation, and community resource referrals.
Example 4: Worth County 78-Year-Old Rural Cognitive Assessment via Telehealth
A 78-year-old woman in Worth County, southwest rural Georgia, has been identified by her Phoebe Worth primary care physician as having cognitive concerns warranting comprehensive evaluation. The nearest comprehensive memory care program is Phoebe Putney Health System (Albany), approximately 30 miles, or Emory Brain Health Center in Atlanta, approximately 175 miles. Given travel burden, the family elects telehealth evaluation with Emory Brain Health Center. The CPT 99483 evaluation is conducted via synchronous audio-video telehealth with the patient and her daughter (caregiver) participating from the daughter's home where the patient is staying for the appointment. MoCA is administered via the video-validated MoCA version. All 10 elements are completed including caregiver assessment, safety assessment (with daughter providing photographs of the home), advance care planning, and comprehensive care plan. Initial diagnosis: probable Alzheimer's disease, mild. Cost-sharing: Part B deductible + 20% coinsurance.
Example 5: Bibb County 82-Year-Old Lewy Body Dementia Evaluation
An 82-year-old man in Bibb County presents to Atrium Health Navicent with a 2-year history of fluctuating cognition, visual hallucinations, REM sleep behavior disorder, and mild parkinsonism. The CPT 99483 evaluation identifies probable dementia with Lewy bodies. All 10 elements are completed including standardized instrument staging (CDR 1.5), neuropsychiatric symptom assessment (hallucinations, REM sleep behavior disorder, mild depression), medication reconciliation with attention to avoiding antipsychotic medications that may cause severe reactions in DLB, safety assessment, caregiver assessment with the wife, advance care planning, and comprehensive care plan including cholinesterase inhibitor initiation, neurology and movement disorder consultation referral, and community resource referrals.
Example 6: Hall County 76-Year-Old Frontotemporal Dementia + CCM Coordination
A 76-year-old man in Hall County is referred to Northeast Georgia neurology for evaluation of 2 years of behavioral changes (impulsivity, disinhibition, apathy) without prominent early memory loss. The CPT 99483 evaluation identifies probable behavioral variant frontotemporal dementia. All 10 elements are completed including caregiver assessment with the wife (substantial caregiver burden related to behavioral symptoms), safety assessment (firearm safety addressed given disinhibition), advance care planning, medication reconciliation, neuropsychiatric symptom assessment, and comprehensive care plan including SSRI for behavioral symptoms, neurology follow-up, behavioral neurology consultation referral, and community resource referrals. Following the CPT 99483 evaluation, the primary care practice initiates Chronic Care Management (CPT 99490) for ongoing coordination across the dementia diagnosis and comorbid hypertension and diabetes. The CPT 99483 and CCM operate in different months — CPT 99483 in the index evaluation month, CCM monthly thereafter.
Fourteen Best Practices for CPT 99483 Implementation
Complete all 10 required elements — Document each of the 10 structural elements explicitly. Missing elements create audit risk and may make the service inappropriate to bill as CPT 99483.
Use standardized instruments consistently — Use validated cognitive testing instruments (MoCA, MMSE, Mini-Cog), functional assessment instruments (Lawton-Brody IADL, Katz ADL), dementia staging instruments (CDR, FAST), and neuropsychiatric assessment instruments (NPI, GDS, PHQ-9) consistently. Document scores in the medical record.
Engage caregivers actively — The caregiver element is structurally required. Schedule visits at times that support caregiver participation and ensure caregiver input is documented in the assessment.
Allocate sufficient time — The typical 50-minute face-to-face duration reflects the substantial work required. Block sufficient appointment time and avoid trying to complete CPT 99483 in a standard 30-minute visit.
Coordinate with AWV — Use the AWV cognitive impairment detection element as the entry point to CPT 99483 evaluation. The AWV-to-99483 pathway represents the principal Medicare framework for early identification of cognitive impairment.
Document the comprehensive care plan in writing — The written care plan is a structural requirement. Document it in the medical record and provide a written copy to the patient/caregiver.
Provide community resource referrals — The Alzheimer's Association Georgia Chapter, local Area Agencies on Aging, adult day programs, support groups, legal/financial planning resources, and other community resources should be specifically identified and shared with patients/caregivers.
Leverage telehealth flexibilities — Use telehealth-delivered CPT 99483 to extend access for rural patients and patients with travel constraints. Document the telehealth modality and consent.
Coordinate with neuropsychological testing — When more detailed cognitive profiling is warranted, refer for neuropsychological testing (CPT 96132-96146) by a neuropsychologist. The neuropsychological testing complements rather than substitutes for CPT 99483.
Address driving safety explicitly — Driving safety is a frequent area of caregiver concern and family conflict. Address it explicitly during the safety assessment with clear documentation. When driving cessation is recommended, document the recommendation.
Address advance care planning meaningfully — The ACP element should engage substantively with the beneficiary's preferences while decision-making capacity remains. Document healthcare power of attorney, treatment preferences, and other ACP discussion.
Plan ongoing care coordination — After CPT 99483 diagnosis and care plan development, plan ongoing care coordination through CCM, BHI, or PCM as appropriate. The CPT 99483 establishes the framework that ongoing care management implements.
Educate beneficiaries on cost-sharing — CPT 99483 is subject to standard Part B cost-sharing. Inform beneficiaries about expected costs and identify QMB/Medigap coverage when applicable.
Document outcomes for quality reporting — Track cognitive assessment outcomes including diagnosis identified, care plan elements implemented, caregiver engagement, and patient/family satisfaction. Quality data supports MIPS reporting and demonstrates cognitive assessment program value.
Fourteen Common CPT 99483 Issues and How to Avoid Them
Missing required elements — Failure to complete all 10 structural elements is the most common audit risk. Use a structured CPT 99483 visit template ensuring all elements are addressed.
Inadequate caregiver involvement — Billing CPT 99483 without documented caregiver participation creates compliance risk. Ensure caregiver involvement is real and documented.
Insufficient time documentation — Document the substantial time spent on the comprehensive evaluation. The typical 50-minute face-to-face duration should be reflected in the documentation.
Inadequate MDM complexity — CPT 99483 requires MDM of moderate or high complexity. Document the MDM elements (problems addressed, data reviewed, risk) supporting the complexity level.
Missing written care plan — The comprehensive written care plan is structurally required. Document it and provide a copy to the patient/caregiver.
Missing community resource referrals — Generic referrals ("referred to community resources") are insufficient. Document specific referrals to named resources.
Failure to use standardized instruments — CPT 99483 requires use of standardized instruments for dementia staging. Document the specific instruments used and the scores.
Inappropriate frequency — CPT 99483 is typically once per year. More frequent billing without substantial change in cognitive status creates audit risk.
Failure to inform beneficiaries of cost-sharing — Inform beneficiaries about Part B cost-sharing before service initiation to avoid billing surprises.
Inappropriate concurrent E/M billing — Billing both CPT 99483 and a separate E/M code for the same cognitive complaint creates duplication concerns. Modifier-25 may support both codes when distinct services are performed.
Missing safety assessment documentation — Safety assessment (driving, home, financial, firearm) is structurally required. Document each domain.
Inadequate neuropsychiatric symptom assessment — Standardized instruments for depression and other neuropsychiatric symptoms should be used and documented.
Failure to coordinate with ongoing care management — CPT 99483 establishes the framework for ongoing care. Plan and document the transition to CCM, BHI, PCM, or specialty follow-up.
Insufficient documentation of advance care planning — The ACP element should be substantively addressed and documented. When more extensive ACP discussion warrants separate billing under CPT 99497/99498, ensure clear documentation distinguishes the work.
Frequently Asked Questions
What is Medicare Cognitive Assessment and Care Plan Services (CPT 99483)?
CPT 99483 is the Medicare code for comprehensive cognitive assessment and care plan services for beneficiaries with cognitive impairment. The code is structurally defined by 10 required elements and a typical 50-minute face-to-face duration. CPT 99483 became effective January 1, 2018, replacing HCPCS G0505 which was effective January 1, 2017 under the CY 2017 Medicare Physician Fee Schedule final rule (CMS-1654-F).
When did Medicare establish the cognitive assessment benefit?
The cognitive assessment benefit was originally established under HCPCS G0505 effective January 1, 2017 under the CY 2017 Medicare Physician Fee Schedule final rule (CMS-1654-F, published November 15, 2016). HCPCS G0505 was replaced by CPT 99483 effective January 1, 2018 under the CY 2018 Medicare Physician Fee Schedule final rule.
What are the 10 required elements of CPT 99483?
(1) Cognition-focused evaluation; (2) Medical decision making of moderate or high complexity; (3) Functional assessment; (4) Use of standardized instruments to stage dementia; (5) Medication reconciliation and high-risk medication review; (6) Evaluation for neuropsychiatric and behavioral symptoms; (7) Safety assessment; (8) Identification of and assessment of caregivers; (9) Advance care planning discussion; (10) Written comprehensive care plan with community resource referrals.
Who is eligible for CPT 99483?
Medicare beneficiaries with suspected or established cognitive impairment including MCI, Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, mixed dementias, and other cognitive disorders. The service supports both initial diagnostic workup and care plan development for established cognitive impairment patients.
Is CPT 99483 free for Medicare beneficiaries?
No. CPT 99483 is subject to standard Part B cost-sharing (deductible + 20% coinsurance). It is NOT subject to the ACA Section 4104 preventive services cost-sharing waiver. Beneficiaries with QMB dual-eligible status or Medigap coverage may have cost-sharing covered.
How often can CPT 99483 be billed?
CPT 99483 is typically billed once per year per beneficiary. Re-evaluation more frequently may be appropriate when there is substantial change in cognitive status warranting comprehensive re-assessment.
Is caregiver participation required for CPT 99483?
The caregiver assessment element of CPT 99483 typically requires caregiver participation in the assessment (in person or via communication technology). The caregiver provides collateral history and is engaged in care planning. Patients without identifiable caregivers may have difficulty meeting this structural element.
Can CPT 99483 be delivered via telehealth?
Yes. CPT 99483 can be delivered via synchronous audio-video telehealth under current Medicare flexibilities. Cognitive testing instruments validated for video administration should be used. Caregivers can participate via video or telephone.
Who can bill CPT 99483?
Physicians (MDs and DOs), nurse practitioners, physician assistants, and clinical nurse specialists can bill CPT 99483. The service is commonly furnished by primary care physicians (family medicine, internal medicine, geriatric medicine), neurologists, geriatric psychiatrists, and other specialty practitioners involved in cognitive disease management.
What is the relationship between AWV cognitive impairment detection and CPT 99483?
The Annual Wellness Visit includes a cognitive impairment detection element under Section 1861(hhh) ACA Section 4103. When AWV identifies cognitive concerns, follow-up CPT 99483 comprehensive evaluation is the appropriate next step. The AWV-to-99483 pathway is the principal Medicare framework for early identification and comprehensive cognitive workup.
Can CPT 99483 and AWV be billed in the same month?
Yes. When both services are clinically appropriate and substantively distinct services are performed, both can be billed in the same calendar month with appropriate documentation.
Can CPT 99483 coexist with CCM, BHI, or PCM?
Yes. CPT 99483 is the comprehensive annual cognitive assessment while CCM (ongoing medical care coordination), BHI (behavioral health management), and PCM (specialist single-condition management) are ongoing monthly services. They can coexist within the same calendar year and can sometimes be billed in the same calendar month.
What standardized cognitive testing instruments are used in CPT 99483?
Common instruments include the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), Mini-Cog, Saint Louis University Mental Status Examination (SLUMS), Memory Impairment Screen (MIS), and others. The specific instrument used depends on clinical context and practitioner preference.
What dementia staging instruments are used?
Common dementia staging instruments include the Clinical Dementia Rating (CDR), Functional Assessment Staging Test (FAST), and Global Deterioration Scale (GDS). These instruments enable systematic documentation of dementia severity.
What is the BOLD Infrastructure for Alzheimer's Act?
The BOLD (Building Our Largest Dementia) Infrastructure for Alzheimer's Act (Public Law 115-406, December 31, 2018; reauthorized 2024) established CDC public health infrastructure for cognitive health surveillance, intervention, and dementia caregiving support. The BOLD Act funds Centers of Excellence, public health programs in state and local health departments, and cognitive health data infrastructure.
What is the National Alzheimer's Project Act (NAPA)?
NAPA (Public Law 111-375, January 4, 2011) established the federal coordination framework for Alzheimer's disease research, services, and public health. NAPA requires development and ongoing updating of a National Plan to Address Alzheimer's Disease and established the Advisory Council on Alzheimer's Research, Care, and Services.
What major Georgia memory care programs deliver CPT 99483?
Major Georgia memory care programs delivering CPT 99483 include Emory Brain Health Center / Emory Goizueta Alzheimer's Disease Research Center (NIA-designated ADRC), Augusta University Brain Health Initiative, Wellstar Memory Health Network, Piedmont memory care, Atrium Health Navicent, Memorial Health, Phoebe Putney Health System, Northeast Georgia Health System, and Atlanta VA Geriatrics.
What is the Georgia State Plan for Alzheimer's Disease and Related Dementias?
The Georgia State Plan for Alzheimer's Disease and Related Dementias is coordinated through the Georgia Department of Human Services Division of Aging Services. The Plan establishes objectives for improving Alzheimer's diagnosis, care, caregiver support, and public health response across Georgia.
How does CPT 99483 support rural Georgia cognitive assessment access?
Telehealth-delivered CPT 99483 extends access to comprehensive memory care programs in metropolitan Georgia for rural beneficiaries. Emory Brain Health Center, Augusta University Brain Health Initiative, and other major programs have expanded telehealth cognitive assessment to support rural Georgia patients. Primary care-delivered CPT 99483 by rural physicians, NPs, and PAs is also appropriate for many cases.
How does CPT 99483 relate to neuropsychological testing?
Neuropsychological testing (CPT 96132, 96133, 96136, 96137, 96138, 96139, 96146) is a separate service typically furnished by a neuropsychologist providing detailed cognitive profiling beyond the bedside cognitive testing performed during CPT 99483. The two services complement each other rather than substitute.
Does CPT 99483 include advance care planning?
The CPT 99483 service includes an advance care planning element. More extensive ACP discussion warrants separate billing under CPT 99497 (first 30 minutes) and CPT 99498 (each additional 30 minutes), with documentation distinguishing the work captured by each code.
What community resources should be referenced in the CPT 99483 care plan?
Common community resource referrals include the Alzheimer's Association Georgia Chapter (1-800-272-3900 24/7 Helpline), local Area Agencies on Aging, adult day programs, dementia-specific support groups (for both patients and caregivers), legal and financial planning resources, in-home care services, respite care programs, and Eldercare Locator (1-800-677-1116).
Can CPT 99483 be billed by primary care physicians?
Yes. Primary care physicians can bill CPT 99483 when furnishing comprehensive cognitive assessment with all 10 required elements. Primary care-delivered cognitive assessment is appropriate for many cases, with specialty referral reserved for complex or atypical presentations.
Does Medicare cover anti-amyloid therapies for Alzheimer's disease?
Medicare coverage for anti-amyloid therapies (e.g., lecanemab) has been established under Medicare Part B with coverage determinations addressing clinical use criteria. Anti-amyloid therapy coverage requires confirmed amyloid pathology (via amyloid PET imaging or CSF biomarker testing), confirmed mild Alzheimer's disease diagnosis, and patient enrollment in CMS-approved registries documenting outcomes. CPT 99483 supports the comprehensive diagnostic workup that informs anti-amyloid therapy eligibility decisions.
What is the role of amyloid PET imaging in cognitive assessment?
Amyloid PET imaging detects beta-amyloid plaques characteristic of Alzheimer's disease pathology. Medicare coverage of amyloid PET has expanded particularly in the context of anti-amyloid therapy eligibility assessment. The IDEAS Study (Imaging Dementia—Evidence for Amyloid Scanning) demonstrated amyloid PET's clinical utility in changing diagnostic and management decisions. Amyloid PET is typically considered after the CPT 99483 comprehensive cognitive assessment when biomarker confirmation is warranted.
CTA: Contacts for Georgia Medicare Cognitive Assessment Resources
Federal Medicare resources
- Medicare — 1-800-MEDICARE (1-800-633-4227), TTY 1-877-486-2048
- Palmetto GBA (Georgia Medicare Administrative Contractor) — 1-866-238-9650
- National Institute on Aging Alzheimer's and related Dementias Education and Referral (ADEAR) Center — 1-800-438-4380
- Eldercare Locator — 1-800-677-1116
Alzheimer's and dementia-specific resources
- Alzheimer's Association 24/7 Helpline — 1-800-272-3900 (24/7, free, confidential, English/Spanish)
- Alzheimer's Association Georgia Chapter — Local chapter offices across Georgia
- Lewy Body Dementia Association
- Association for Frontotemporal Degeneration
Georgia state and academic medical center resources
- Georgia Department of Human Services Division of Aging Services
- Georgia Department of Public Health Alzheimer's Disease and Related Dementias program — 404-657-2700
- Emory Brain Health Center / Emory Goizueta Alzheimer's Disease Research Center
- Augusta University Brain Health Initiative
- Atlanta VA Geriatrics Service
- Georgia DCH Medicaid Member Services — 1-866-211-0950
- GeorgiaCares SHIP — 1-866-552-4464
Advocacy and consumer assistance
- Medicare Rights Center — 1-800-333-4114
- Atlanta Legal Aid Society — 404-377-0701 (elder law)
- Georgia Legal Services Program — 1-800-498-9469
- 211 Georgia — Dial 211
- Acentra Health (Georgia QIO) — 1-844-455-8708
Social Security
- Social Security Administration — 1-800-772-1213
Conclusion: Why Cognitive Assessment Coverage Matters for Every Georgia Medicare Beneficiary
The Medicare Cognitive Assessment and Care Plan Services benefit (CPT 99483, with HCPCS G0505 predecessor) represents the dedicated federal payment infrastructure recognizing that comprehensive cognitive assessment requires substantially more clinical work than standard E/M codes capture. The 10 required structural elements — cognition-focused evaluation, MDM of moderate or high complexity, functional assessment, standardized dementia staging instruments, medication reconciliation, neuropsychiatric symptom assessment, safety assessment, caregiver assessment, advance care planning, and comprehensive written care plan with community resource referrals — collectively define what comprehensive cognitive assessment must include and provide the structural framework that distinguishes CPT 99483 from generic E/M evaluation.
For Georgia Medicare beneficiaries, the cognitive assessment benefit operates within a state landscape with approximately 189,000 Georgia residents age 65+ living with Alzheimer's disease and a substantial population with MCI. The Georgia memory care infrastructure anchored by the Emory Goizueta Alzheimer's Disease Research Center (NIA-designated ADRC), Emory Brain Health Center, Augusta University Brain Health Initiative, and additional programs at Wellstar, Piedmont, Atrium Health Navicent, Memorial Health, Phoebe Putney, Northeast Georgia, and the Atlanta VA provides comprehensive cognitive assessment capacity. Telehealth-delivered CPT 99483 expanding access to rural Georgia represents an important access pathway closing geographic gaps.
The federal framework supporting cognitive assessment continues to expand. The National Alzheimer's Project Act (2011), the 21st Century Cures Act (2016), the BOLD Infrastructure for Alzheimer's Act (2018, reauthorized 2024), and ongoing CMS payment innovation including CPT 99483 collectively represent the most substantial federal commitment to cognitive health in U.S. history. The Georgia State Plan for Alzheimer's Disease and Related Dementias operationalizes this federal framework at the state level with objectives for improving diagnosis, care, caregiver support, and public health response.
Every Georgia Medicare beneficiary with suspected or established cognitive impairment deserves a comprehensive cognitive assessment that goes beyond a routine office visit to address the full complexity of cognitive disease management. The CPT 99483 benefit makes this comprehensive assessment financially sustainable for primary care practices and specialty memory care programs. The work of expanding CPT 99483 utilization across Georgia primary care — particularly in rural counties where cognitive assessment access is most constrained — represents one of the most consequential opportunities in Georgia Medicare policy for improving early diagnosis, supporting family caregivers, and improving outcomes for the older Georgians living with cognitive disease and the families who care for them.